TGF-B (beta) receptor inhibitor
98%
- Product Code: 63054
CAS:
476474-11-0
| Molecular Weight: | 328.3672 g./mol | Molecular Formula: | C₂₀H₁₆N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
TGF-B receptor inhibitors are primarily used in research and therapeutic applications to study and modulate the TGF-beta signaling pathway, which plays a critical role in cell growth, differentiation, and immune regulation. In cancer research, these inhibitors are employed to block TGF-beta signaling, which is often hijacked by tumors to promote metastasis and immune evasion. By inhibiting this pathway, researchers aim to reduce tumor progression and enhance the effectiveness of anti-cancer therapies. Additionally, TGF-B receptor inhibitors are explored in fibrotic diseases, such as liver or lung fibrosis, where excessive TGF-beta signaling contributes to tissue scarring. Inhibiting this pathway can potentially slow or reverse fibrotic damage. In autoimmune diseases, these inhibitors are investigated for their ability to suppress overactive immune responses driven by TGF-beta signaling. Overall, TGF-B receptor inhibitors serve as valuable tools in both understanding disease mechanisms and developing targeted treatments.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿40,275.00 |
+
-
|
TGF-B (beta) receptor inhibitor
TGF-B receptor inhibitors are primarily used in research and therapeutic applications to study and modulate the TGF-beta signaling pathway, which plays a critical role in cell growth, differentiation, and immune regulation. In cancer research, these inhibitors are employed to block TGF-beta signaling, which is often hijacked by tumors to promote metastasis and immune evasion. By inhibiting this pathway, researchers aim to reduce tumor progression and enhance the effectiveness of anti-cancer therapies. Additionally, TGF-B receptor inhibitors are explored in fibrotic diseases, such as liver or lung fibrosis, where excessive TGF-beta signaling contributes to tissue scarring. Inhibiting this pathway can potentially slow or reverse fibrotic damage. In autoimmune diseases, these inhibitors are investigated for their ability to suppress overactive immune responses driven by TGF-beta signaling. Overall, TGF-B receptor inhibitors serve as valuable tools in both understanding disease mechanisms and developing targeted treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :